These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 11859130

  • 1. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
    Shibagaki N, Udey MC.
    J Immunol; 2002 Mar 01; 168(5):2393-401. PubMed ID: 11859130
    [Abstract] [Full Text] [Related]

  • 2. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
    Mitsui H, Inozume T, Kitamura R, Shibagaki N, Shimada S.
    J Invest Dermatol; 2006 Aug 01; 126(8):1804-12. PubMed ID: 16645583
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma.
    Shibagaki N, Udey MC.
    Eur J Immunol; 2003 Apr 01; 33(4):850-60. PubMed ID: 12672050
    [Abstract] [Full Text] [Related]

  • 4. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K.
    J Immunol; 1999 Jan 01; 162(1):144-51. PubMed ID: 9886380
    [Abstract] [Full Text] [Related]

  • 5. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H, Okamoto T, Kanzaki M, Inozume T, Shibagaki N, Shimada S.
    Br J Dermatol; 2010 Jan 01; 162(1):29-41. PubMed ID: 19863514
    [Abstract] [Full Text] [Related]

  • 6. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N, Saito T, Masunaga Y, Tsukada Y, Nakagawa S, Mizuguchi H, Mori K, Okada Y, Fujita T, Hayakawa T, Mayumi T, Yamamoto A.
    Cancer Res; 2001 Nov 01; 61(21):7913-9. PubMed ID: 11691812
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A, Gilboa E.
    J Exp Med; 1995 Jul 01; 182(1):255-60. PubMed ID: 7540653
    [Abstract] [Full Text] [Related]

  • 8. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
    Schnell S, Young JW, Houghton AN, Sadelain M.
    J Immunol; 2000 Feb 01; 164(3):1243-50. PubMed ID: 10640737
    [Abstract] [Full Text] [Related]

  • 9. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
    Tanaka Y, Koido S, Ohana M, Liu C, Gong J.
    J Immunol; 2005 Feb 01; 174(3):1274-80. PubMed ID: 15661883
    [Abstract] [Full Text] [Related]

  • 10. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L, Sad S, Patel GB, Sprott GD.
    J Immunol; 2000 Nov 01; 165(9):5177-85. PubMed ID: 11046050
    [Abstract] [Full Text] [Related]

  • 11. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A, Snyder D, Gilboa E.
    J Immunol; 1996 Apr 15; 156(8):2918-26. PubMed ID: 8609412
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB, Eriksson K, Li BL, Lindblad M, Azem J, Holmgren J.
    Clin Immunol; 2004 Jul 15; 112(1):35-44. PubMed ID: 15207780
    [Abstract] [Full Text] [Related]

  • 13. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S, Yuan J, Xiang J.
    J Leukoc Biol; 2007 Oct 15; 82(4):829-38. PubMed ID: 17626150
    [Abstract] [Full Text] [Related]

  • 14. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells.
    Tanaka Y, Dowdy SF, Linehan DC, Eberlein TJ, Goedegebuure PS.
    J Immunol; 2003 Feb 01; 170(3):1291-8. PubMed ID: 12538688
    [Abstract] [Full Text] [Related]

  • 15. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC, Liu SJ, Chen HW, Shen KY, Leng CH.
    Oncotarget; 2016 May 24; 7(21):30804-19. PubMed ID: 27127171
    [Abstract] [Full Text] [Related]

  • 16. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S, Vervaert CE, Burch J, Grichnik J, Seigler HF, Darrow TL.
    Int J Cancer; 1999 Nov 12; 83(4):532-40. PubMed ID: 10508491
    [Abstract] [Full Text] [Related]

  • 17. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y, Zhang J, Mi Z, Robbins P, Falo LD.
    J Immunol; 2005 Mar 15; 174(6):3808-17. PubMed ID: 15749922
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J.
    J Immunol; 2010 Nov 01; 185(9):5268-78. PubMed ID: 20881190
    [Abstract] [Full Text] [Related]

  • 19. Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells.
    Faiola B, Doyle C, Gilboa E, Nair S.
    Immunology; 2002 Jan 01; 105(1):47-55. PubMed ID: 11849314
    [Abstract] [Full Text] [Related]

  • 20. Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A*0201 transgenic mice.
    Justesen S, Buus S, Claesson MH, Pedersen AE.
    Immunology; 2007 Nov 01; 122(3):326-34. PubMed ID: 17610503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.